In contrast to FSHD2 individuals, BAMS patients show no signs of muscular dystrophy while SMCHD1 mutations in FSHD2 are not associated with craniofacial defects, which are characteristic for BAMS. This evidence concerns the gene SMCHD1 and muscular dystrophy.